CVRx, Inc. Earnings Per Share (Diluted)
CVRx, Inc. (CVRX) reported Earnings Per Share (Diluted) of -$0.53 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- CVRx, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.53.
- CVRx, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.50.
- CVRx, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.46.
- CVRx, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.49.
- CVRx, Inc. earnings per share, diluted for fiscal 2025 was -$2.04.
- CVRx, Inc. earnings per share, diluted for fiscal 2024 was -$2.65.
- CVRx, Inc. earnings per share, diluted for fiscal 2023 was -$1.99.
- CVRx, Inc. earnings per share, diluted for fiscal 2022 was -$2.02.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.53 10-Q · filed 2026-08-06 | -$1.03 10-Q · filed 2026-08-06 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.97 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | -$0.50 10-Q · filed 2026-05-12 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$2.01 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.04 10-K · filed 2026-02-13 | ||
| 2025-09-30 | -$0.49 10-Q · filed 2025-11-06 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.59 10-Q · filed 2025-11-06 | -$2.02 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$0.57 10-Q · filed 2026-08-06 | -$1.10 10-Q · filed 2026-08-06 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-03-31 | -$0.53 10-Q · filed 2026-05-12 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$2.17 derived: net income ÷ weighted average shares · filed 2026-05-12 | ||
| 2024-12-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$2.65 10-K · filed 2026-02-13 | ||
| 2024-09-30 | -$0.57 10-Q · filed 2025-11-06 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$2.25 10-Q · filed 2025-11-06 | -$2.71 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2024-06-30 | -$0.65 10-Q · filed 2025-08-05 | -$1.69 10-Q · filed 2025-08-05 | -$2.14 derived: net income ÷ weighted average shares · filed 2025-08-05 | -$2.57 derived: net income ÷ weighted average shares · filed 2025-08-05 | ||
| 2024-03-31 | -$1.04 10-Q · filed 2025-05-09 | -$1.49 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$1.93 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$2.49 derived: net income ÷ weighted average shares · filed 2025-05-09 | ||
| 2023-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$0.87 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$1.44 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$1.99 10-K · filed 2025-02-18 | ||
| 2023-09-30 | -$0.43 10-Q · filed 2024-11-01 | -$1.00 derived: net income ÷ weighted average shares · filed 2024-11-01 | -$1.55 10-Q · filed 2024-11-01 | -$2.06 derived: net income ÷ weighted average shares · filed 2024-11-01 | ||
| 2023-06-30 | -$0.56 10-Q · filed 2024-08-02 | -$1.11 10-Q · filed 2023-08-03 | -$1.62 derived: net income ÷ weighted average shares · filed 2024-08-02 | -$2.10 derived: net income ÷ weighted average shares · filed 2024-08-02 | ||
| 2023-03-31 | -$0.55 10-Q · filed 2024-05-10 | -$1.06 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$2.08 derived: net income ÷ weighted average shares · filed 2024-05-10 | ||
| 2022-12-31 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-02-09 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-02-09 | -$1.53 derived: net income ÷ weighted average shares · filed 2024-02-09 | -$2.02 10-K · filed 2024-02-09 | ||
| 2022-09-30 | -$0.48 10-Q · filed 2023-10-31 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-10-31 | -$1.51 10-Q · filed 2023-10-31 | -$2.02 derived: net income ÷ weighted average shares · filed 2023-10-31 | ||
| 2022-06-30 | -$0.54 10-Q · filed 2023-08-03 | -$0.49 10-Q · filed 2022-08-01 | -$1.03 10-Q · filed 2023-08-03 | -$0.49 10-Q · filed 2022-08-01 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-08-03 | -$1.85 derived: net income ÷ weighted average shares · filed 2023-08-03 |
| 2022-03-31 | -$0.49 10-Q · filed 2023-05-11 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2.89 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||
| 2021-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$0.82 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$2.52 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$4.16 10-K · filed 2023-02-10 | ||
| 2021-09-30 | -$0.30 10-Q · filed 2022-11-04 | -$2.33 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$4.66 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | -$48.48 10-Q · filed 2022-08-01 | -$72.58 10-Q · filed 2022-08-01 | ||||
| 2021-03-31 | -$23.92 10-Q · filed 2022-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |